BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$962M |
| 2 |
Amazon
AMZN
|
+$682M |
| 3 |
Apple
AAPL
|
+$231M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$200M |
| 5 |
Broadcom
AVGO
|
+$172M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.19B |
| 2 |
SPDR S&P Biotech ETF
XBI
|
+$457M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$421M |
| 4 |
Motorola Solutions
MSI
|
+$353M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$323M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Consumer Discretionary | 10.5% |
| 3 | Financials | 9.56% |
| 4 | Healthcare | 8.43% |
| 5 | Communication Services | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Glaukos
GKOS
$4.75B
| $947K | ﹤0.01% |
21,301
-23,192
| -52% | -$1.03M |
|
|
PVLA
1927
Palvella Therapeutics, Inc. Common Stock
PVLA
$629M
| $946K | ﹤0.01% |
3,128
+3,117
| +28,336% | +$943K |
|
1928
AstraZeneca
AZN
$247B
| $946K | ﹤0.01% |
16,237
-285,831
| -95% | -$16.6M |
|
1929
Sally Beauty Holdings
SBH
$1.48B
| $943K | ﹤0.01% |
51,082
-59,464
| -54% | -$1.1M |
|
1930
Timken Company
TKR
$5.4B
| $941K | ﹤0.01% |
13,577
-14,060
| -51% | -$974K |
|
1931
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38.8B
| $939K | ﹤0.01% |
+17,107
| New | +$939K |
|
1932
Omeros
OMER
$282M
| $939K | ﹤0.01% |
146,011
+135,228
| +1,254% | +$870K |
|
|
SASR
1933
DELISTED
Sandy Spring Bancorp Inc
SASR
| $931K | ﹤0.01% |
19,362
+6,412
| +50% | +$308K |
|
1934
Brink's
BCO
$4.83B
| $928K | ﹤0.01% |
14,159
+5,137
| +57% | +$337K |
|
|
APTO
1935
DELISTED
Aptose Biosciences, Inc.
APTO
| $926K | ﹤0.01% |
1,525
+768
| +101% | +$466K |
|
1936
Flex
FLEX
$21.4B
| $921K | ﹤0.01% |
66,700
-393,895
| -86% | -$5.44M |
|
|
SA
1937
Seabridge Gold
SA
$1.92B
| $920K | ﹤0.01% |
55,807
+50,607
| +973% | +$835K |
|
1938
WEX
WEX
$5.82B
| $920K | ﹤0.01% |
6,554
+926
| +16% | +$130K |
|
1939
Lindsay Corp
LNN
$1.52B
| $919K | ﹤0.01% |
6,049
-5,633
| -48% | -$856K |
|
1940
Axalta
AXTA
$6.75B
| $917K | ﹤0.01% |
27,702
-28,680
| -51% | -$950K |
|
|
COWN
1941
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $915K | ﹤0.01% |
25,339
-23,896
| -49% | -$863K |
|
1942
iShares Global Infrastructure ETF
IGF
$8.22B
| $914K | ﹤0.01% |
19,201
+18,905
| +6,387% | +$900K |
|
1943
BioCryst Pharmaceuticals
BCRX
$1.66B
| $912K | ﹤0.01% |
65,856
+21,952
| +50% | +$304K |
|
1944
American Woodmark
AMWD
$995M
| $911K | ﹤0.01% |
13,978
-10,920
| -44% | -$712K |
|
|
RETA
1945
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $908K | ﹤0.01% |
34,442
+12,483
| +57% | +$329K |
|
|
RPT
1946
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $906K | ﹤0.01% |
67,750
-22,264
| -25% | -$298K |
|
1947
Standex International
SXI
$2.47B
| $906K | ﹤0.01% |
8,185
-4,793
| -37% | -$530K |
|
1948
Artisan Partners
APAM
$3.27B
| $902K | ﹤0.01% |
18,934
-1,450
| -7% | -$69.1K |
|
1949
Cabot Corp
CBT
$4.2B
| $902K | ﹤0.01% |
16,041
+2,382
| +17% | +$134K |
|
1950
Sabesp
SBS
$16B
| $899K | ﹤0.01% |
122,526
+20,531
| +20% | +$151K |
|